Sort   by:  
 Page size 
UnknownLatent Tuberculosis Infection and the Risk of Subsequent Cancer.
Not available
S-EPMC5291550 | biostudies-literature
UnknownTheoretical insight into OH- and Cl-initiated oxidation of CF3OCH(CF3)2 and CF3OCF2CF2H &fate of CF3OC(X•)(CF3)2 and CF3OCF2CF2X• radicals (X=O, O2).
Not available
S-EPMC5220334 | biostudies-literature
UnknownMapping stages, barriers and facilitators to the implementation of HEARTS in the Americas initiative in 12 countries: A qualitative study.
Not available
S-EPMC8678790 | biostudies-literature
ProteomicsHSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B cell receptor signaling
Burkitt’s lymphoma (BL) is an aggressive B-cell neoplasm that is currently treated by intensive chemotherapy in combination with anti-CD20 antibodies. Because of their toxicity, current treatment regimens are often not suitable for elderly patients or for patients in developing countries where BL is...
ORGANISM(S): Homo sapiens (Human) 
2017-01-02 | PXD004181 | Pride
Hsp90 Burkitt’s lymphoma Bcr signaling Mass spectrometry Syk Phosphoproteomics 
ProteomicsComparative proteomics reveals a diagnostic signature for pulmonary head-and-neck cancer metastasis.
This study represents a proteomic resource for HNSCC and SQCLC with quantitative protein expression data for 7800 proteins and provides a proteomic diagnostic signature for classification for undetermined secondary lung tumors in HNSCC patients. By quantitative mass-spectrometry-based proteomics, we...
ORGANISM(S): Homo sapiens (Human) 
2018-08-06 | PXD007705 | Pride
Head and neck cancer Human tissue proteomics Lung cancer Squamous cell carcinoma Diagnostic biomarker Metastasis 
UnknownPhase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors.
Not available
S-EPMC7954579 | biostudies-literature
UnknownDiet Quality Scores and Prediction of All-Cause, Cardiovascular and Cancer Mortality in a Pan-European Cohort Study.
Not available
S-EPMC4943719 | biostudies-literature
ProteomicsHSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B cell receptor signaling
Burkitt’s lymphoma (BL) is an aggressive B-cell neoplasm that is currently treated by intensive chemotherapy in combination with anti-CD20 antibodies. Because of their toxicity, current treatment regimens are often not suitable for elderly patients or for patients in developing countries where BL is...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2017-03-29 | MSV000080781 | MassIVE
UnknownArachidonic acid activates NLRP3 inflammasome in MDSCs via FATP2 to promote post-transplant tumour recurrence in steatotic liver grafts.
Not available
S-EPMC10616418 | biostudies-literature
UnknownGenetic regulation of liver lipids in a mouse model of insulin resistance and hepatic steatosis.
Not available
S-EPMC7792507 | biostudies-literature
Sort   by:  
 Page size